Results 111 to 120 of about 183,390 (190)

Development and characterization of high-affinity aptamers for HIV protease detection. [PDF]

Heliyon
Valadés-Alcaraz A, Reinosa R, González-Hevilla M, Medina-Sánchez C, Holguín Á.   +4 more
europepmc   +1 more source

The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. [PDF]

Sci Transl Med, 2021
Caffall ZF, Wilkes BJ, Hernández-Martinez R, Rittiner JE, Fox JT, Wan KK, Shipman MK, Titus SA, Zhang YQ, Patnaik S, Hall MD, Boxer MB, Shen M, Li Z, Vaillancourt DE, Calakos N.   +15 more
europepmc   +1 more source

Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation. [PDF]

Int J Mol Sci
Crispo F, Vassallo A, Faraone I, Santarsiere A, Chiummiento L, Martinelli M, Cascelli N, Fernàndez-Busquets X, Miglionico R, Nigro I, Caddeo C, Armentano MF.   +11 more
europepmc   +1 more source

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect. [PDF]

Antiviral Res, 2022
Foo CS, Abdelnabi R, Kaptein SJF, Zhang X, Ter Horst S, Mols R, Delang L, Rocha-Pereira J, Coelmont L, Leyssen P, Dallmeier K, Vergote V, Heylen E, Vangeel L, Chatterjee AK, Annaert PP, Augustijns PF, De Jonghe S, Jochmans D, Gouwy M, Cambier S, Vandooren J, Proost P, van Laer C, Weynand B, Neyts J.   +25 more
europepmc   +1 more source

In Silico Evaluation of HIV Protease and RNA Polymerase Inhibitors as Potential COVID-19 Therapeutics. [PDF]

Cureus
Devaraji M, Ravikumar L.
europepmc   +1 more source

The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes. [PDF]

Cancers (Basel)
Pomella S, D'Archivio L, Cassandri M, Aiello FA, Melaiu O, Marampon F, Rota R, Barillari G.   +7 more
europepmc   +1 more source

Improving Treatment Outcome for Children with HIV [PDF]

, 2011
Calmy, Alexandra L, Ford, Nathan
core   +2 more sources

Novel combinatorial approach: Harnessing HIV protease inhibitors to enhance amphotericin B's antifungal efficacy in cryptococcosis. [PDF]

PLoS One
Alkashef NM, Seleem MN.
europepmc   +1 more source

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir. [PDF]

Cancers (Basel), 2020
Subeha MR, Telleria CM.
europepmc   +1 more source

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma. [PDF]

Cancer Res, 2021
Besse L, Besse A, Stolze SC, Sobh A, Zaal EA, van der Ham AJ, Ruiz M, Phuyal S, Büchler L, Sathianathan M, Florea BI, Borén J, Ståhlman M, Huber J, Bolomsky A, Ludwig H, Hannich JT, Loguinov A, Everts B, Berkers CR, Pilon M, Farhan H, Vulpe CD, Overkleeft HS, Driessen C.   +24 more
europepmc   +1 more source